Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide vs Mesalazine in Acute Ulcerative Proctitis
NCT01966783Phase 2Completed
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- Sep 2013
- Primary completion
- Aug 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of budesonide in ulcerative proctitis, sponsored by Dr. Falk Pharma GmbH. Started Sep 2013; status: completed.
02
Drugs
budesonide
03
Conditions
ulcerative proctitis
Beyond the preview
Go deeper on NCT01966783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01966783.